181 related articles for article (PubMed ID: 23892932)
1. Decreased liver peroxisomal β-oxidation accompanied by changes in brain fatty acid composition in aged rats.
Yang L; Zhang Y; Wang S; Zhang W; Shi R
Neurol Sci; 2014 Feb; 35(2):289-93. PubMed ID: 23892932
[TBL] [Abstract][Full Text] [Related]
2. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomal beta-oxidation and steatohepatitis.
Rao MS; Reddy JK
Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
[TBL] [Abstract][Full Text] [Related]
5. [Peroxisomal beta-oxidation].
Mannaerts GP; Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
7. Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha.
Hu T; Foxworthy P; Siesky A; Ficorilli JV; Gao H; Li S; Christe M; Ryan T; Cao G; Eacho P; Michael MD; Michael LF
Endocrinology; 2005 Dec; 146(12):5380-7. PubMed ID: 16123164
[TBL] [Abstract][Full Text] [Related]
8. Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver.
Asayama K; Sandhir R; Sheikh FG; Hayashibe H; Nakane T; Singh I
Mol Cell Biochem; 1999 Apr; 194(1-2):227-34. PubMed ID: 10391144
[TBL] [Abstract][Full Text] [Related]
9. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα.
Tahri-Joutey M; Andreoletti P; Surapureddi S; Nasser B; Cherkaoui-Malki M; Latruffe N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445672
[TBL] [Abstract][Full Text] [Related]
11. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
[TBL] [Abstract][Full Text] [Related]
12. Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha).
Hostetler HA; Kier AB; Schroeder F
Biochemistry; 2006 Jun; 45(24):7669-81. PubMed ID: 16768463
[TBL] [Abstract][Full Text] [Related]
13. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
Xu Y; Denning KL; Lu Y
Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats.
Ouali F; Djouadi F; Merlet-Bénichou C; Riveau B; Bastin J
Pediatr Res; 2000 Nov; 48(5):691-6. PubMed ID: 11044493
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha.
Glosli H; Gudbrandsen OA; Mullen AJ; Halvorsen B; Røst TH; Wergedahl H; Prydz H; Aukrust P; Berge RK
Biochim Biophys Acta; 2005 Jun; 1734(3):235-46. PubMed ID: 15893958
[TBL] [Abstract][Full Text] [Related]
16. Induction of peroxisomal fatty acid beta-oxidation and liver fatty acid-binding protein by peroxisome proliferators. Mediation via the cytochrome P-450IVA1 omega-hydroxylase pathway.
Kaikaus RM; Chan WK; Lysenko N; Ray R; Ortiz de Montellano PR; Bass NM
J Biol Chem; 1993 May; 268(13):9593-603. PubMed ID: 8486647
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I.
Kaikaus RM; Sui Z; Lysenko N; Wu NY; Ortiz de Montellano PR; Ockner RK; Bass NM
J Biol Chem; 1993 Dec; 268(36):26866-71. PubMed ID: 8262919
[TBL] [Abstract][Full Text] [Related]
19. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected].
Vluggens A; Andreoletti P; Viswakarma N; Jia Y; Matsumoto K; Kulik W; Khan M; Huang J; Guo D; Yu S; Sarkar J; Singh I; Rao MS; Wanders RJ; Reddy JK; Cherkaoui-Malki M
Lab Invest; 2010 May; 90(5):696-708. PubMed ID: 20195242
[TBL] [Abstract][Full Text] [Related]
20. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
